Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RIPK1 | Q13546 | 2/20 | 0.39 |
| ▸ | ACACB | O00763 | 1/20 | 0.34 |
| ▸ | ACACA | Q13085 | 1/20 | 0.34 |
| ▸ | FDPS | P14324 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.30 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8896856 | 0.89 | RIPK1 (0.44) | RIPK1ACACBACACATSHR | |
| SCHEMBL7404026 | 0.85 | FFAR4 (0.41) | RIPK1ACACBACACAFDPSFFAR4 | |
| SCHEMBL8388721 | 0.83 | ACACB (0.48) | RIPK1ACACBACACAFDPSFFAR4 | |
| SCHEMBL8641193 | 0.83 | FFAR4 (0.48) | ACACBACACAFDPSFFAR4FFAR1 | |
| SCHEMBL15855762 | 0.83 | FDPS (0.43) | FDPSTSHRLMNAFFAR4FFAR1 | |
| SCHEMBL29232764 | 0.83 | FDPS (0.43) | FDPSTSHRLMNAFFAR4FFAR1 | |
| SCHEMBL1328891 | 0.83 | FDPS (0.43) | FDPSTSHRLMNAFFAR4FFAR1 | |
| SCHEMBL28568549 | 0.83 | FDPS (0.43) | FDPSTSHRLMNAFFAR4FFAR1 | |
| SCHEMBL30575792 | 0.83 | FDPS (0.43) | FDPSTSHRLMNAFFAR4FFAR1 | |
| SCHEMBL7787347 | 0.82 | ALDH1A1 (0.43) | ACACBACACAFDPSTSHRLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108531315-A | A kind of adult's liquid detergent containing licorice | 内蒙古伊草恋生物科技有限责任公司 | 2018-09-14 | — | — | CN | disclosed |
| EP-2588246-A1 | PROCESS FOR PREPARING A THIXOTROPING AGENT AND USE THEREOF | Construction Research & Technology GmbH (DE) | 2013-05-08 | — | — | EP | disclosed |
| WO-2012000774-A1 | PROCESS FOR PREPARING A THIXOTROPING AGENT AND USE THEREOF | CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) | 2012-01-05 | — | — | WO | disclosed |
| US-20110144090-A1 | COMPOUNDS AND METHODS OF USE THEREOF | GALENEA CORPORATION | 2011-06-16 | — | — | US | disclosed |
| CN-101889092-A | Biofuel production | BIO ARCHITECTURE LAB INC | 2010-11-17 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110144090-A1 | COMPOUNDS AND METHODS OF USE THEREOF | AANAT, HNMT, INMT | RIPK1 2177/4885ACACB 433/4885ACACA 842/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.